Clinical trial
BIOTRONIKS - Safety and Performance in de NOvo Lesion of NatiVE Coronary Arteries With Magmaris- Registry: BIOSOLVE-IV
NCT02817802 is registered in ClinicalTrials.gov with Biotronik AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BIOTRONIKS - Safety and Performance in de NOvo Lesion of NatiVE Coronary Arteries With Magmaris- Registry: BIOSOLVE-IV
- Lead sponsor
- Biotronik AG
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 31, 2016
- Completion date
- October 31, 2025
- Enrollment
- 2,066 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.